Critical Ovarian Hyperstimulation Syndrome After In Vitro Fertilization Treatment in a Renal Transplant Recipient: A Case Report

被引：4

作者：

Zheng, H. -H. ^{[1
]}

Song, Y. ^{[2
]}

Wu, J. -Y. ^{[2
]}

机构：

[1] Wenzhou Med Univ, Dongyang Peoples Hosp, Dongyang, Peoples R China

[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China

来源：

TRANSPLANTATION PROCEEDINGS | 2016年 / 48卷 / 01期

关键词：

EPITHELIUM-DERIVED FACTOR; PATIENT;

D O I：

10.1016/j.transproceed.2016.01.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Objective. The study sought to describe a case of critical ovarian hyperstimulation syndrome (OHSS) after in vitro fertilization treatment in a renal transplant recipient. Patient. A 35-year-old woman with a 5-year history of renal transplantation underwent in vitro fertilization treatment with a midluteal pituitary downregulation regimen. Result. There are only 7 cases published regarding successful pregnancies outcomes after in vitro fertilization treatment in renal transplant recipients. In the most of the case reports, there was no deterioration of graft function. However, our patient developed critical OHSS. After effective treatment, her serum creatinine level decreased from 668 mu mol/L to baseline. Conclusions. Our case demonstrates that the highly specialized care and close cooperation of transplantation and perinatology teams are required when undergoing in vitro fertilization treatment in renal transplant recipients.

引用

页码：267 / 270

页数：4

共 14 条

[1] Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures [J].

Aboulghar, MA ;

Mansour, RT .

HUMAN REPRODUCTION UPDATE, 2003, 9 (03) :275-289

[2] Regulation of vascular permeability by vascular endothelial growth factors [J].

Bates, DO ;

Harper, SJ .

VASCULAR PHARMACOLOGY, 2002, 39 (4-5) :225-237

[3] Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021) [J].

Cai, J ;

Jiang, WG ;

Grant, MB ;

Boulton, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) :3604-3613

[4] The Role of Pigment Epithelium-Derived Factor in the Pathophysiology and Treatment of Ovarian Hyperstimulation Syndrome in Mice [J].

Chuderland, Dana ;

Ben-Ami, Ido ;

Kaplan-Kraicer, Ruth ;

Grossman, Hadas ;

Ron-El, Raphael ;

Shalgi, Ruth .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02) :E258-E266

[5]

Kasum M, 2010, COLLEGIUM ANTROPOL, V34, P1139

[6] Ovarian hyperstimulation syndrome and its effect on renal function in a renal transplant patient undergoing IVF treatment [J].

Khalaf, Y ;

Elkington, N ;

Anderson, H ;

Taylor, A ;

Braude, P .

HUMAN REPRODUCTION, 2000, 15 (06) :1275-1277

[7] SUCCESSFUL PREGNANCY OUTCOME IN A RENAL-TRANSPLANT PATIENT FOLLOWING IN-VITRO FERTILIZATION [J].

LOCKWOOD, GM ;

LEDGER, WL ;

BARLOW, DH .

HUMAN REPRODUCTION, 1995, 10 (06) :1528-1530

[8] Distinction between early and late ovarian hyperstimulation syndrome [J].

Mathur, RS ;

Akande, AV ;

Keay, SD ;

Hung, LP ;

Jenkins, JM .

FERTILITY AND STERILITY, 2000, 73 (05) :901-907

[9] SUCCESSFUL PREGNANCIES AFTER HUMAN RENAL TRANSPLANTATION [J].

MURRAY, JE ;

MERRILL, JP ;

REID, DE ;

HARRISON, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1963, 269 (07) :341-&

[10]

Naredi Nikita, 2014, Med J Armed Forces India, V70, P58, DOI 10.1016/j.mjafi.2012.03.005

← 1 2 →